$NVCR
NovoCure Ltd

2024 Q4 Form 10-Q Financial Statement

#000164511324000031 Filed on October 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $155.1M
YoY Change 21.81%
Cost Of Revenue $35.37M
YoY Change 10.22%
Gross Profit $119.7M
YoY Change 25.72%
Gross Profit Margin 77.19%
Selling, General & Admin $99.93M
YoY Change 0.08%
% of Gross Profit 83.47%
Research & Development $51.88M
YoY Change -3.25%
% of Gross Profit 43.34%
Depreciation & Amortization $2.458M
YoY Change -12.53%
% of Gross Profit 2.05%
Operating Expenses $151.8M
YoY Change -1.08%
Operating Profit -$32.09M
YoY Change -44.9%
Interest Expense $10.51M
YoY Change 5.07%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$21.59M
YoY Change -55.24%
Income Tax $8.985M
% Of Pretax Income
Net Earnings -$30.57M
YoY Change -38.22%
Net Earnings / Revenue -19.71%
Basic Earnings Per Share -$0.28
Diluted Earnings Per Share -$0.28
COMMON SHARES
Basic Shares Outstanding 108.2M shares 108.2M shares
Diluted Shares Outstanding 108.2M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $959.9M
YoY Change 4.2%
Cash & Equivalents $185.4M
Short-Term Investments $774.5M
Other Short-Term Assets $3.777M
YoY Change 122.18%
Inventory $39.10M
Prepaid Expenses
Receivables $67.06M
Other Receivables $25.44M
Total Short-Term Assets $1.095B
YoY Change 4.51%
LONG-TERM ASSETS
Property, Plant & Equipment $73.25M
YoY Change 60.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $12.22M
YoY Change -1.55%
Total Long-Term Assets $126.7M
YoY Change 28.84%
TOTAL ASSETS
Total Short-Term Assets $1.095B
Total Long-Term Assets $126.7M
Total Assets $1.222B
YoY Change 6.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $91.32M
YoY Change 14.58%
Accrued Expenses
YoY Change
Deferred Revenue $14.87M
YoY Change
Short-Term Debt $557.3M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $735.0M
YoY Change 367.67%
LONG-TERM LIABILITIES
Long-Term Debt $97.15M
YoY Change -82.9%
Other Long-Term Liabilities $18.00K
YoY Change -76.0%
Total Long-Term Liabilities $126.2M
YoY Change -78.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $735.0M
Total Long-Term Liabilities $126.2M
Total Liabilities $861.2M
YoY Change 14.42%
SHAREHOLDERS EQUITY
Retained Earnings -$1.088B
YoY Change 15.96%
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $360.8M
YoY Change
Total Liabilities & Shareholders Equity $1.222B
YoY Change 6.6%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$30.57M
YoY Change -38.22%
Depreciation, Depletion And Amortization $2.458M
YoY Change -12.53%
Cash From Operating Activities $10.38M
YoY Change -153.72%
INVESTING ACTIVITIES
Capital Expenditures $10.68M
YoY Change 47.29%
Acquisitions
YoY Change
Other Investing Activities $20.88M
YoY Change -14.83%
Cash From Investing Activities $10.19M
YoY Change -40.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00
YoY Change
Cash From Financing Activities $100.0K
YoY Change -91.46%
NET CHANGE
Cash From Operating Activities $10.38M
Cash From Investing Activities $10.19M
Cash From Financing Activities $100.0K
Net Change In Cash $20.76M
YoY Change -2213.65%
FREE CASH FLOW
Cash From Operating Activities $10.38M
Capital Expenditures $10.68M
Free Cash Flow -$307.0K
YoY Change -98.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001645113
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
NovoCure Limited
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
Y9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1057807
dei Entity Address Address Line2
EntityAddressAddressLine2
Grenville Street
dei Entity Address City Or Town
EntityAddressCityOrTown
St. Helier
dei Entity Address Country
EntityAddressCountry
JE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
240821000 usd
CY2024Q3 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
774476000 usd
CY2023Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
669795000 usd
CY2024Q3 us-gaap Restricted Cash Current
RestrictedCashCurrent
3777000 usd
CY2023Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
1743000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
61221000 usd
CY2024Q3 nvcr Receivables And Prepaid Expenses
ReceivablesAndPrepaidExpenses
25437000 usd
CY2023Q4 nvcr Receivables And Prepaid Expenses
ReceivablesAndPrepaidExpenses
22677000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
39096000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
38152000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1095268000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1034409000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
73251000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51479000 usd
CY2024Q3 nvcr Field Equipment Net Noncurrent
FieldEquipmentNetNoncurrent
12913000 usd
CY2023Q4 nvcr Field Equipment Net Noncurrent
FieldEquipmentNetNoncurrent
11384000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
28330000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
34835000 usd
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
111720000 usd
CY2024Q3 us-gaap Assets
Assets
1221986000 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
108100392 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
108100392 shares
CY2024Q3 us-gaap Revenues
Revenues
155095000 usd
CY2023Q3 us-gaap Revenues
Revenues
127321000 usd
us-gaap Revenues
Revenues
443954000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
119723000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
95229000 usd
us-gaap Gross Profit
GrossProfit
340239000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40103000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41887000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
117344000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
151815000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
153474000 usd
us-gaap Operating Expenses
OperatingExpenses
447431000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-32092000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-58245000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-107192000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
26749000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-30570000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-49485000 usd
us-gaap Net Income Loss
NetIncomeLoss
-102705000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
108247716 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108247716 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106772814 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106772814 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106219194 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106219194 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-30570000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-49485000 usd
us-gaap Net Income Loss
NetIncomeLoss
-102705000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
64000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
826000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-161000 usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
15000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
108201434 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
185422000 usd
CY2023Q4 us-gaap Assets
Assets
1146129000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
35372000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
32092000 usd
us-gaap Cost Of Revenue
CostOfRevenue
103715000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
51882000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
53623000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
158435000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21585000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-48222000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-75956000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8985000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1263000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
107679501 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107679501 shares
CY2024Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
1927000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
852000 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-252000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-32433000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-49496000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-102614000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-49485000 usd
us-gaap Net Income Loss
NetIncomeLoss
-102705000 usd
CY2024Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2458000 usd
CY2023Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2803000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8131000 usd
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
31364000 usd
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
26346000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
97278000 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
503000 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-1398000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-763000 usd
CY2024Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-6737000 usd
CY2023Q3 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-6691000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-18972000 usd
CY2024Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1895000 usd
CY2023Q3 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4080000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
867000 usd
CY2024Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-1906000 usd
CY2023Q3 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-3971000 usd
CY2023Q3 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3075000 usd
CY2024Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10683000 usd
CY2023Q3 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7253000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33913000 usd
CY2024Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
190000000 usd
CY2023Q3 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
275549000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
608000000 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10193000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17258000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-118031000 usd
CY2024Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2187000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
168443000 usd
CY2023 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
223062000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
171652000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
167621000 usd
us-gaap Net Income Loss
NetIncomeLoss
-159964000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-207043000 usd
dei Entity Address Address Line1
EntityAddressAddressLine1
No. 4 The Forum
dei Trading Symbol
TradingSymbol
NVCR
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
14022000 usd
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
126718000 usd
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
JE2 4UF
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
67060000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12224000 usd
CY2024Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
59830000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
57964000 usd
CY2024Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
10507000 usd
CY2023Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
10023000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
31236000 usd
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.51
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
242564000 usd
dei Amendment Flag
AmendmentFlag
false
us-gaap Number Of Reporting Units
NumberOfReportingUnits
1 segment
dei City Area Code
CityAreaCode
44 (0) 15
dei Local Phone Number
LocalPhoneNumber
3475 6700
dei Security12b Title
Security12bTitle
Ordinary Shares, no par value
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
557333000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2024Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
91319000 usd
CY2023Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
94391000 usd
CY2024Q3 nvcr Other Accounts Payable Lease Liabilities And Accrued Expenses Current
OtherAccountsPayableLeaseLiabilitiesAndAccruedExpensesCurrent
86350000 usd
CY2023Q4 nvcr Other Accounts Payable Lease Liabilities And Accrued Expenses Current
OtherAccountsPayableLeaseLiabilitiesAndAccruedExpensesCurrent
84724000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
735002000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
179115000 usd
CY2024Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
568822000 usd
CY2024Q3 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
97149000 usd
CY2023Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
0 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
21144000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27420000 usd
CY2024Q3 nvcr Employee Related Liabilities Non Current
EmployeeRelatedLiabilitiesNonCurrent
7892000 usd
CY2023Q4 nvcr Employee Related Liabilities Non Current
EmployeeRelatedLiabilitiesNonCurrent
8258000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
18000 usd
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
126203000 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
604518000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
861205000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
783633000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
107075754 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
107075754 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1454367000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1353468000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5378000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-5469000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1088208000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-985503000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
360781000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
362496000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1221986000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1146129000 usd
us-gaap Revenues
Revenues
375554000 usd
CY2023 us-gaap Revenues
Revenues
509338000 usd
us-gaap Cost Of Revenue
CostOfRevenue
95724000 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
128280000 usd
us-gaap Gross Profit
GrossProfit
279830000 usd
CY2023 us-gaap Gross Profit
GrossProfit
381058000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
168754000 usd
CY2023 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
226809000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
124609000 usd
CY2023 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
164057000 usd
us-gaap Operating Expenses
OperatingExpenses
460984000 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
613928000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-181154000 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-232870000 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
27948000 usd
CY2023 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
41130000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-153206000 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-191740000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6758000 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15303000 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.95
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.95
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106391178 shares
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106391178 shares
us-gaap Net Income Loss
NetIncomeLoss
-159964000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-207043000 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1655000 usd
CY2023 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1473000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
440000 usd
CY2023 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
445000 usd
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
1654000 usd
CY2023 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
4954000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-159523000 usd
CY2023 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-210079000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
362496000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
34084000 usd
CY2024Q1 nvcr Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures
213000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1322000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-38760000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
359355000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31830000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2187000 usd
CY2024Q2 nvcr Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures
1121000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
632000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-33375000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
361750000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
31364000 usd
CY2024Q3 nvcr Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures
100000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1863000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-30570000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
360781000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
441170000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
39084000 usd
CY2023Q1 nvcr Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures
5211000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-258000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-53061000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
432146000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32740000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2883000 usd
CY2023Q2 nvcr Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures
4622000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
710000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-57418000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
415683000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26346000 usd
CY2023Q3 nvcr Stock Issued During Period Value Stock Options Exercised And Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueStockOptionsExercisedAndRestrictedStockAwardForfeitures
1171000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
0 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-11000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-49485000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
393704000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-30570000 usd
us-gaap Net Income Loss
NetIncomeLoss
-159964000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-207043000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
8246000 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10969000 usd
CY2024Q3 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-1213000 usd
CY2023Q3 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
480000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
60000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
530000 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-95000 usd
CY2024Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
450000 usd
CY2023Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
112000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
784000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
374000 usd
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
493000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
98170000 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
115608000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-2185000 usd
CY2023 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-161000 usd
CY2024Q3 nvcr Increase Decrease In Accounts Receivables And Prepaid Expenses
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpenses
-5411000 usd
CY2023Q3 nvcr Increase Decrease In Accounts Receivables And Prepaid Expenses
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpenses
-2642000 usd
nvcr Increase Decrease In Accounts Receivables And Prepaid Expenses
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpenses
8983000 usd
nvcr Increase Decrease In Accounts Receivables And Prepaid Expenses
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpenses
-24094000 usd
CY2023 nvcr Increase Decrease In Accounts Receivables And Prepaid Expenses
IncreaseDecreaseInAccountsReceivablesAndPrepaidExpenses
-29414000 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-15822000 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-23084000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8250000 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
8919000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-7969000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-3585000 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-4072000 usd
CY2024Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
7452000 usd
CY2023Q3 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6265000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1245000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3992000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
14869000 usd
CY2024Q3 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1537000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-5131000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-7934000 usd
CY2023 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-9781000 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10376000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-19314000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22918000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-58778000 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-73336000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20272000 usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
27093000 usd
us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
916433000 usd
CY2023 us-gaap Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities
1214982000 usd
CY2024Q3 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
169124000 usd
CY2023Q3 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
251038000 usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
692118000 usd
us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
810513000 usd
CY2023 us-gaap Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
1003741000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
85648000 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
184148000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2883000 usd
CY2023 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4416000 usd
CY2024Q3 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2023Q3 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
96922000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2023 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
CY2024Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
CY2023Q3 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
12913000 usd
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10000 usd
CY2023 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10000 usd
CY2024Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
100000 usd
CY2023Q3 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1171000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1434000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11004000 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
11381000 usd
CY2024Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
100000 usd
CY2023Q3 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1171000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
87630000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13877000 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15787000 usd
CY2024Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87000 usd
CY2023Q3 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-97000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-46000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-69000 usd
CY2023 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
20756000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-982000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-53365000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
40678000 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
126730000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
157494000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115834000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
115834000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
189199000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156512000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
189199000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156512000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
242564000 usd
CY2024Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
6637000 usd
CY2023Q3 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1202000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
17053000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8745000 usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
13665000 usd
CY2024Q3 us-gaap Interest Paid Net
InterestPaidNet
2964000 usd
CY2023Q3 us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
4934000 usd
us-gaap Interest Paid Net
InterestPaidNet
1000 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
6000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
185422000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154860000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
185422000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
154860000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
240821000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3777000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1652000 usd
CY2024Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3777000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1652000 usd
CY2023Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1743000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
189199000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156512000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
189199000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
156512000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
242564000 usd
CY2024Q3 nvcr Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Disposals
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfDisposals
757000 usd
CY2023Q3 nvcr Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Disposals
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfDisposals
4693000 usd
nvcr Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Disposals
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfDisposals
-610000 usd
nvcr Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Disposals
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfDisposals
10477000 usd
CY2023 nvcr Right Of Use Asset Obtained In Exchange For Operating Lease Liability Net Of Disposals
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityNetOfDisposals
18063000 usd
CY2024Q3 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
201000 usd
CY2023Q3 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
0 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
201000 usd
us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
0 usd
CY2023 us-gaap Noncash Or Part Noncash Acquisition Value Of Assets Acquired1
NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1
1714000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top:12pt;text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Concentration Risks. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's cash, cash equivalents, short-term investments and trade receivables are potentially subject to a concentration of risk. Cash, cash equivalents and short-term investments are invested at top tier financial institutions globally and the total value invested at any one institution is limited pursuant to the Company's investment policy. These investments may be in excess of insured limitations or not insured in certain jurisdictions. Generally, these investments may be redeemed upon demand according to the terms of the securities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company's trade receivables are due from numerous governments and federal and state agencies that are paid from their respective budgets, and from hundreds of health insurance companies. The Company does not believe that there are significant default risks associated with these governments, agencies and health insurance companies based upon the Company's historical experience.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company has no off-balance sheet concentrations of credit risk such as foreign exchange contracts, option contracts or other foreign hedging arrangements.</span></div>
CY2024Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
575066000 usd
CY2024Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
2136000 usd
CY2024Q3 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
1000 usd
CY2024Q3 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
577201000 usd
CY2024Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
575066000 usd
CY2024Q3 nvcr Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities Amortized Cost
CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecuritiesAmortizedCost
959898000 usd
CY2024Q3 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain
2136000 usd
CY2024Q3 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Loss
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss
1000 usd
CY2024Q3 nvcr Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities Fair Value
CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecuritiesFairValue
962033000 usd
CY2024Q3 nvcr Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities
CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecurities
959898000 usd
CY2023Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
520326000 usd
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Gain
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingGain
554000 usd
CY2023Q4 us-gaap Held To Maturity Securities Accumulated Unrecognized Holding Loss
HeldToMaturitySecuritiesAccumulatedUnrecognizedHoldingLoss
259000 usd
CY2023Q4 us-gaap Held To Maturity Securities Fair Value
HeldToMaturitySecuritiesFairValue
520621000 usd
CY2023Q4 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
520326000 usd
CY2023Q4 nvcr Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities Amortized Cost
CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecuritiesAmortizedCost
910616000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Gain
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedGain
554000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale And Held To Maturity Cumulative Unrecognized Loss
DebtSecuritiesAvailableForSaleAndHeldToMaturityCumulativeUnrecognizedLoss
259000 usd
CY2023Q4 nvcr Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities Fair Value
CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecuritiesFairValue
910911000 usd
CY2023Q4 nvcr Cash Cash Equivalents Available For Sale And Held To Maturity Debt Securities
CashCashEquivalentsAvailableForSaleAndHeldToMaturityDebtSecurities
910616000 usd
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
8869000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
10265000 usd
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
10342000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
9796000 usd
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
19885000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
18091000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
39096000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
38152000 usd
CY2024Q3 us-gaap Deposits Assets
DepositsAssets
2350000 usd
CY2023Q4 us-gaap Deposits Assets
DepositsAssets
2848000 usd
CY2024Q3 us-gaap Contractual Obligation
ContractualObligation
2720000 usd
CY2023Q4 us-gaap Contractual Obligation
ContractualObligation
3216000 usd
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
557333000 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 usd
CY2024Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
568822000 usd
CY2024Q3 us-gaap Revenues
Revenues
155095000 usd
CY2023Q3 us-gaap Revenues
Revenues
127321000 usd
us-gaap Revenues
Revenues
443954000 usd
us-gaap Revenues
Revenues
375554000 usd
CY2023 us-gaap Revenues
Revenues
509338000 usd
CY2024Q3 us-gaap Revenues
Revenues
155095000 usd
CY2023Q3 us-gaap Revenues
Revenues
127321000 usd
us-gaap Revenues
Revenues
443954000 usd
us-gaap Revenues
Revenues
375554000 usd
CY2023 us-gaap Revenues
Revenues
509338000 usd
CY2024Q3 nvcr Accounts Receivable Excluding Unbilled Receivables
AccountsReceivableExcludingUnbilledReceivables
61316000 usd
CY2023Q4 nvcr Accounts Receivable Excluding Unbilled Receivables
AccountsReceivableExcludingUnbilledReceivables
56970000 usd
CY2024Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
5744000 usd
CY2023Q4 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
4251000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
14866000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
16224000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
16224000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
18028000 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
18028000 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
8539507 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
40.07
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3797704 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
15.88
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
184633 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.77
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
719823 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
50.14
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
11432755 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.92
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6804138 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
35.14
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
31364000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
26346000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
97278000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
98170000 usd
CY2023 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
115608000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-30570000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-49485000 usd
us-gaap Net Income Loss
NetIncomeLoss
-102705000 usd
us-gaap Net Income Loss
NetIncomeLoss
-159964000 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-207043000 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
108247716 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106772814 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
107679501 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106219194 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106391178 shares
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14618813 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8936955 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
13472270 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7976099 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8535785 shares
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.28
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.28
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.46
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.46
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.95
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.51
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.51
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.95
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.95
CY2024Q3 us-gaap Noncurrent Assets
NoncurrentAssets
86164000 usd
CY2023Q4 us-gaap Noncurrent Assets
NoncurrentAssets
62863000 usd
CY2023Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated
RestructuringAndRelatedCostNumberOfPositionsEliminated
200 employee
CY2023Q4 us-gaap Restructuring And Related Cost Number Of Positions Eliminated Period Percent
RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
0.13
CY2024Q3 us-gaap Restructuring Costs
RestructuringCosts
0 usd
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
0 usd
us-gaap Restructuring Costs
RestructuringCosts
2003000 usd
us-gaap Restructuring Costs
RestructuringCosts
0 usd
CY2023 us-gaap Restructuring Costs
RestructuringCosts
6231000 usd
CY2024Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
0 usd
CY2023Q3 us-gaap Payments For Restructuring
PaymentsForRestructuring
0 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
5455000 usd
us-gaap Payments For Restructuring
PaymentsForRestructuring
0 usd
CY2023 us-gaap Payments For Restructuring
PaymentsForRestructuring
2753000 usd
CY2024Q3 nvcr Employee Benefit And Share Based Payment Arrangement Reversal Of Accrual
EmployeeBenefitAndShareBasedPaymentArrangementReversalOfAccrual
0 usd
nvcr Employee Benefit And Share Based Payment Arrangement Reversal Of Accrual
EmployeeBenefitAndShareBasedPaymentArrangementReversalOfAccrual
369000 usd
CY2023 nvcr Employee Benefit And Share Based Payment Arrangement Reversal Of Accrual
EmployeeBenefitAndShareBasedPaymentArrangementReversalOfAccrual
3041000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
0 usd
us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
1991000 usd
CY2023 us-gaap Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
9313000 usd
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false

Files In Submission

Name View Source Status
0001645113-24-000031-index-headers.html Edgar Link pending
0001645113-24-000031-index.html Edgar Link pending
0001645113-24-000031.txt Edgar Link pending
0001645113-24-000031-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nvcr-20240930.htm Edgar Link pending
nvcr-20240930.xsd Edgar Link pending
nvcr-20240930xexx311.htm Edgar Link pending
nvcr-20240930xexx312.htm Edgar Link pending
nvcr-20240930xexx321.htm Edgar Link pending
nvcr-20240930xexx322.htm Edgar Link pending
nvcr-20240930_g1.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
nvcr-20240930_def.xml Edgar Link unprocessable
nvcr-20240930_lab.xml Edgar Link unprocessable
nvcr-20240930_pre.xml Edgar Link unprocessable
nvcr-20240930_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
nvcr-20240930_cal.xml Edgar Link unprocessable